FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series C / Biotech startups that raised Series C in Switzerland

Biotech startups that raised Series C in Switzerland

Updated 16 Nov 2026

Reset
Biotech startups that raised Series C in Switzerland
One-time CSV
  • 20 funded companies, 13 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-c~switzerland.csv20 rows × 18 columns
CompanyCityLast roundAmountDate
CutissZürichSeries C$38.8M2025-09-10
NumabWädenswilSeries C$54.8M2025-01-09
ImmunOs TherapeuticsSchlierenSeries C$11.0M2024-09-17
AsceneuronLausanneSeries C$100.0M2024-07-16
Bright Peak TherapeuticsAllschwilSeries C$90.0M2024-06-11
Memo TherapeuticsSchlierenSeries C$22.0M2024-05-07
NanoliveEcublensSeries C$2.2M2022-09-20
NBE-TherapeuticsBaselSeries C$22.0M2020-01-10

8 rows of the CSV in 5 of its 18 columns.

20
Startups
$1.1B
Total raised
0
Funded in the last 12 months
0
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

10 of 20
10 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Cutiss Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. Biotech Zürich Series C $38.8M 2025-09-10 $94.6M Innosuisse 11 to 50 2017
ImmunOs Therapeutics ImmunOs Therapeutics is a clinical-stage biotechnology company. Biotech Schlieren Series C $11.0M 2024-09-17 Lightspeed Venture Partners, Innosuisse, Mission BioCapital +1 11 to 50 2014
Asceneuron Asceneuron develops therapeutics for orphan tauopathies and Alzheimer's disease. Biotech Lausanne Series C $100.0M 2024-07-16 OrbiMed, Novo Holdings, EQT Life Sciences +1 1 to 10 2012
Memo Therapeutics Memo Therapeutics conducts biotechnology research in antibody discovery and immune repertoire analysis. Biotech Schlieren Series C $22.0M 2024-05-07 $108.8M Verve Ventures, Kurma Partners, Pureos Bioventures +1 11 to 50 2012
NBE-Therapeutics NBE-Therapeutics develops oncology treatments for cancer patients. Biotech Basel Series C $22.0M 2020-01-10 $65.7M Novo Holdings, Boehringer Ingelheim Venture Fund, PPF Group 11 to 50 2012
dacadoo dacadoo offers digital lifestyle solutions through mobile apps from its base in Switzerland. Biotech Zürich Series C $71.1M 2019-12-13 Samsung Ventures 51 to 100 2010
Andrew Alliance Andrew Alliance is a Swiss pioneer in robotics for the life sciences sector. Artificial intelligence Geneva Series C $14.0M 2018-06-12 Venture Kick, Omega Funds, Rancilio Cube Sicaf 11 to 50 2011
Endosense Endosense develops medical technology that improves the reproducibility of catheter ablation for cardiac arrhythmias. Biotech Geneva Series C $41.2M 2013-11-27 3i Group, VI Partners, Andera Partners +2 51 to 100 2003
Viroblock Viroblock is a Swiss company developing antiviral technology for air filtration products. Biotech Geneva Series C $4.5M 2012-02-14 $4.5M StartAngels Network, BlueOcean Ventures 1 to 10 2005
Synosia Therapeutics Synosia Therapeutics develops and commercializes products for unmet needs in psychiatry and neurology. Biotech Basel Series C $30.0M 2010-10-12 $94.0M Novo Holdings, Versant Ventures, 5AM Ventures +2 1 to 10 2006

Table 1. Biotech startups that raised Series C in Switzerland: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Novo Holdings Corporate venture arm Hellerup, Denmark 3 15%
2 Innosuisse Government investment office Berne, Switzerland 2 10%
3 BlackRock Investment bank New York, United States 2 10%
4 Venture Kick Startup incubator Schlieren, Switzerland 2 10%
5 StartAngels Network Angel group Zürich, Switzerland 2 10%
6 BlueOcean Ventures Venture capital firm Plan-les-ouates, Switzerland 2 10%
7 Cormorant Asset Management Hedge fund Boston, United States 1 5%
8 Biotechnology Value Fund Venture capital firm San Francisco, United States 1 5%
9 RTW Investments Hedge fund New York, United States 1 5%
10 Mitsubishi UFJ Capital Corporate venture arm Tokyo, Japan 1 5%
11 Mission BioCapital Venture capital firm Cambridge, United States 1 5%
12 Lightspeed Venture Partners Venture capital firm Menlo Park, United States 1 5%
13 Samsara BioCapital Private equity firm Palo Alto, United States 1 5%
14 SR One Venture capital firm Cambridge, United States 1 5%
15 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 1 5%

Table 2. Biotech startups that raised Series C in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 16 80% $1.1B
Software 3 15%
Hardware 2 10%
Fintech 1 5%
Artificial intelligence 1 5%

Table 3. Biotech startups that raised Series C in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 20 100% $25.9M

Table 4. Biotech startups that raised Series C in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Geneva 4 20%
Schlieren 3 15%
Zürich 2 10%
Wädenswil 2 10%
Basel 2 10%
Lausanne 1 5%
Allschwil 1 5%
Cham 1 5%
Ecublens 1 5%
Epalinges 1 5%
Plan-les-ouates 1 5%
Landquart 1 5%

Table 5. Biotech startups that raised Series C in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2025 2 10% $93.6M
2024 4 20% $223.0M
2023 1 5% $25.9M
2022 1 5% $2.2M
2020 1 5% $22.0M
2019 2 10% $79.1M

Table 6. Biotech startups that raised Series C in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2015 to 2019 2 10%
2010 to 2014 10 50%
Before 2010 8 40%

Table 7. Biotech startups that raised Series C in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 6 30%
11 to 50 9 45%
51 to 100 4 20%
101 to 250 1 5%

Table 8. Biotech startups that raised Series C in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Switzerland whose last round is Series C are on the list?
20, in the file dated 16 November 2026.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series C in Switzerland: 20 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Switzerland

Cite: FundingWatcher, 20 biotech companies in Switzerland whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-c/switzerland/